Syngene International Ltd Faces Bearish Momentum Amid Technical Indicator Shifts

1 hour ago
share
Share Via
Syngene International Ltd, a small-cap player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, moving from mildly bearish to a more pronounced bearish trend. Recent technical indicators such as MACD, RSI, Bollinger Bands, and moving averages reveal a complex picture of weakening price momentum, signalling caution for investors amid a challenging market backdrop.
Syngene International Ltd Faces Bearish Momentum Amid Technical Indicator Shifts

Technical Trend Overview and Price Movement

As of 23 Jul 2026, Syngene International’s stock price closed at ₹406.40, down 1.93% from the previous close of ₹414.40. The intraday range saw a high of ₹419.20 and a low of ₹404.85, hovering near its 52-week low of ₹380.00 and significantly below its 52-week high of ₹728.40. This price action underscores the stock’s ongoing struggle to regain upward momentum amid broader sectoral and market pressures.

The technical trend has shifted from mildly bearish to bearish, reflecting a deterioration in the stock’s short- and medium-term outlook. Daily moving averages remain bearish, indicating that the stock price is trading below key average levels, which often acts as resistance to upward price movement.

MACD and Momentum Oscillators Signal Divergent Trends

The Moving Average Convergence Divergence (MACD) indicator presents a nuanced view. On a weekly basis, the MACD remains mildly bullish, suggesting some underlying positive momentum in the short term. However, the monthly MACD is bearish, signalling that the longer-term trend is weakening. This divergence between weekly and monthly MACD readings highlights the stock’s current volatility and the potential for further downside if the longer-term bearish trend dominates.

Similarly, the Know Sure Thing (KST) oscillator aligns with this mixed picture: mildly bullish on the weekly timeframe but bearish on the monthly. This suggests that while short-term momentum may offer some relief rallies, the broader trend remains under pressure.

RSI and Bollinger Bands Confirm Bearish Pressure

The Relative Strength Index (RSI) on both weekly and monthly charts currently shows no clear signal, hovering in neutral territory. This lack of momentum confirmation from RSI indicates that the stock is neither oversold nor overbought, leaving room for further directional movement based on other technical factors.

Bollinger Bands, however, paint a more bearish picture. Both weekly and monthly Bollinger Bands are signalling bearish conditions, with the stock price trending near the lower band. This often indicates increased selling pressure and heightened volatility, which can precede further declines or consolidation at lower levels.

Volume and Dow Theory Insights

On-Balance Volume (OBV) analysis reveals a split scenario: weekly OBV is mildly bearish, reflecting recent selling pressure, while monthly OBV is bullish, suggesting accumulation over a longer horizon. This discrepancy may indicate that institutional investors are selectively accumulating shares despite short-term weakness.

Dow Theory assessments reinforce the bearish stance, with both weekly and monthly readings mildly bearish. This theory, which focuses on confirming trends through market averages, suggests that the stock’s broader trend is aligned with a downward trajectory.

Momentum just kicked in! This Small Cap from the Auto - Trucks sector entered our list with explosive short-term signals. Catch the wave while it's still building!

  • - Fresh momentum detected
  • - Explosive short-term signals
  • - Early wave positioning

Catch the Wave Now →

Comparative Performance Against Sensex

Syngene International’s recent returns have lagged significantly behind the benchmark Sensex index. Over the past week, the stock declined by 3.39%, compared to a modest 0.56% gain in the Sensex. The one-month performance shows an 8.35% drop for Syngene versus a 0.44% decline in the Sensex, while year-to-date losses stand at a steep 37.56% against the Sensex’s 9.93% fall.

Longer-term returns further highlight the stock’s underperformance. Over one year, Syngene’s share price has fallen 39.87%, while the Sensex gained 6.61%. Over three and five years, the stock has declined 47.74% and 35.22% respectively, contrasting sharply with Sensex gains of 15.10% and 45.27%. Even over a decade, while Syngene has delivered a positive 91.18% return, it remains well behind the Sensex’s 176.07% growth.

Mojo Score and Rating Update

MarketsMOJO assigns Syngene International a Mojo Score of 37.0, reflecting a Sell rating. This is an upgrade from the previous Strong Sell grade issued on 16 Apr 2026, signalling a slight improvement in outlook but still cautioning investors against aggressive buying. The small-cap classification further emphasises the stock’s higher risk profile within the Healthcare Services sector.

The downgrade in technical trend from mildly bearish to bearish, combined with the mixed signals from momentum indicators, suggests that investors should remain vigilant. The current technical environment does not favour a sustained rally, and the stock may continue to face downward pressure unless there is a significant shift in fundamentals or market sentiment.

Outlook and Investor Considerations

Given the prevailing bearish technical indicators and the stock’s underperformance relative to the broader market, investors should approach Syngene International with caution. The bearish daily moving averages and monthly MACD suggest that any short-term rallies may be met with resistance. Meanwhile, the neutral RSI and mixed OBV readings imply that the stock could consolidate before a clearer directional trend emerges.

Investors seeking exposure to the Healthcare Services sector might consider monitoring Syngene’s technical indicators closely for signs of a reversal, such as a sustained break above key moving averages or a bullish crossover in MACD on the monthly chart. Until then, the stock’s risk-reward profile remains skewed towards downside risk.

Why settle for Syngene International Ltd? SwitchER evaluates this Healthcare Services small-cap against peers, other sectors, and market caps to find you superior investment opportunities!

  • - Comprehensive evaluation done
  • - Superior opportunities identified
  • - Smart switching enabled

Discover Superior Stocks →

Summary

Syngene International Ltd’s technical landscape is currently dominated by bearish signals, with key indicators such as moving averages, Bollinger Bands, and monthly MACD pointing to weakening price momentum. While some weekly indicators like MACD and KST show mild bullishness, these are insufficient to offset the broader negative trend. The stock’s significant underperformance relative to the Sensex over multiple timeframes further compounds concerns.

Investors should weigh these technical signals carefully against their risk tolerance and investment horizon. Until a clear technical reversal materialises, Syngene International remains a cautious proposition within the Healthcare Services sector.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News